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Fluorescence properties of a biologically active benzothienopyridopyrimidone in solution and in lipid
vesicles are reported. Assays at different pH values (0.5–10) allowed the determination of pKa =
2.0, showing that this compound may be useful as a pH indicator for pH ≤ 4. In lipid vesicles,
benzothienopyridopyrimidone locates in a water-rich environment, indicating that it can be carried in
the hydrophilic region of liposomes for drug delivery applications.
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INTRODUCTION
Natural tetracyclic heteroaromatic planar com-
pounds, like ellipticine and olivacine (derivatives of car-
bazoles and pyridines), are known as anti-tumor com-
pounds. Synthetic analogues are being evaluated in order
to obtain more active and less toxic compounds, and they
are also being studied for other types of biological activity.
A new tetracyclic benzothienopyridopyrimidone 1
(Fig. 1) was obtained by us [1], and it was subjected to
some biological activity studies. Preliminary studies of
antimicrobial activity evidenced selectivity against Bacil-
lus cereus (gram-positive) among representative bacteria
and antifungal activity against a Candida albicans species
[1]. Recent studies on the antiproliferative activity of com-
pound 1 in a panel of human tumor cell lines showed a
remarkable cytotoxicity upon UVA irradiation [2].
In previous DNA intercalation studies, compound
1 has shown a low affinity toward the macromolecule
[2] and, therefore, we turned our attention to the study
of its interaction with lipid membranes. Here we report
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fluorescence studies on benzothienopyridopyrimidone 1
in homogeneous solution, varying the solvent and pH, and
the fluorescence properties of compound 1 when incorpo-
rated in lipid vesicles of neutral phospholipids (DPPC
and DOPE) and of a cationic lipid (DODAB). The neutral
phospholipids DPPC and DOPE are major components of
biological membranes, while cationic liposomes based in
DODAB have been used as vehicles for DNA transfection
and drug delivery [3–5].
EXPERIMENTAL
Materials and Methods
All the solutions were prepared using spectroscopic
grade solvents and ultrapure water (Milli-Q grade). Buffer
solutions of variable pH were prepared from a mixed so-
lution of 0.2 M boric acid/0.05 M citric acid and a 0.1 M
solution of sodium phosphate, as described by Perrin and
Dempsey [6]. All buffers were adjusted in the pH range
0.5–10 by addition of HCl or NaOH solution.
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC), 1,2-Dioleoyl-sn-glycero-3-phosphoethanola-
ABBREVIATIONS: DPPC, dipalmitoyl phosphatidylcholine; DOPE,
dioleoyl phosphatidylethanolamine; DODAB, dioctadecyldimethy-
lammonium bromide.
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Fig. 1. Structure of the benzothienopyridopyrimidone.
mine (DOPE), both from Sigma, and dioctadecyldimethy-
lammonium bromide (DODAB), from Tokyo Kasei,
were used as received (lipid structures are shown below).
Lipid/probe films were prepared from stock solutions in
chloroform, by evaporation of solvent under a nitrogen
stream. Vesicles were formed by hydration of lipids with
an aqueous buffer solution (20 mM HEPES and 10 mM
NaCl), at room temperature for DOPE and at 60◦C for
DODAB and DPPC (above transition temperature of both
lipids, ca. 45◦C [7] and 41◦C [8], respectively), followed
by bath-sonication to obtain optically clear solutions
[7,9]. The final lipid concentration was 1 mM, with a
probe/lipid molar ratio of 1:500. The vesicle solutions
were cooled to room temperature and stored for 24 hr
prior to measurements.
Spectroscopic Measurements
Absorption spectra were recorded in a Shimadzu UV-
3101PC UV-Vis-NIR spectrophotometer. Fluorescence
measurements were performed using a Spex Fluorolog
2 spectrofluorimeter. For fluorescence quantum yield de-
termination, the solutions were previously bubbled for
20 min with ultrapure nitrogen. Fluorescence spectra were
corrected for the instrumental response of the system.
The fluorescence quantum yields (s) were deter-
mined using the standard method (Eq. 1) [10,11]. 9,10-
diphenylanthracene in ethanol was used as reference,
r = 0.95 [12].
s =
[(
ArFsn
2
s
)/(
AsFrn
2
r
)]
r (1)
where A is the absorbance at the excitation wavelength, F
the integrated emission area and n the refraction index of
the solvents used. Subscripts refer to the reference (r) or
sample (s) compound.
RESULTS AND DISCUSSION
Absorption spectra of benzothienopyridopyrimidone
1 in different solvents are shown in Fig. 2. It can be ob-
served that the absorption maxima shift to higher energies
(blue shift) with the increase of solvent polarity, thus in-
dicating that a n→π∗ transition is involved [13]. Despite
this, the molar extinction coefficients at absorption max-
ima (366–370 nm) are typical of a π→π∗ transition (ε
values are close to 104 M−1 cm−1), suggesting that the
two electronic states are nearby in energy, resulting in
state-mixing [14].
Figure 3 shows the fluorescence spectra of compound
1 in several solvents. A loss of vibrational structure is
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Fig. 2. Absorption spectra of compound 1 (4×10−6 M) in several solvents.
observed in polar organic solvents, which is a common
behaviour in several solvatochromic probes [15,16]. How-
ever, in our case, the emission maximum exhibits only a
small solvent dependence. This weak dependence on sol-
vent polarity is also observed in the fluorescence quan-
tum yields (Table I). The presence of the S atom in the
compound structure can promote the intersystem crossing
process by enhancement of spin-orbit coupling interac-
tion [14], justifying the low fluorescence quantum yields
observed.
The spectrum in water is different in shape and
the emission maximum wavelength exhibits a blue shift
Fig. 3. Normalized fluorescence spectra of benzothienopyridopyrimidone 1 (4×10−6 M) in
different solvents (λexc = 368 nm).
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Table I. Fluorescence Quantum yields (F) and maximum
Absorption and Emission Wavelengths (λabs and λem) for
Benzothienopyridopyrimidone in different solvents
Solvent λabs (nm) λem (nm) F a
Cyclohexane 370 428 0.12
Toluene 370 437 0.18
Dichloromethane 369 436 0.13
Dimethylsulfoxide 368 441 0.16
Acetonitrile 367 437 0.13
Ethanol 367 436 0.12
Methanol 366 435 0.12
Water 366 418 0.14
aRelative to 9,10-diphenylanthracene in ethanol
(r = 0.95 [12]).
relative to the other solvents. One possible explanation
for this behaviour could be the formation of a hydrogen
bond between water and compound 1 in ground state,
which becomes weaker in the excited state. The possibil-
ity of compound aggregation in water was ruled out from
the measurement of emission at several concentrations
(5×10−6 M, 10−6 M and 5×10−7 M), the spectral shape
being maintained.
The dependence on pH of the benzothienopyridopy-
rimidone 1 emission was also investigated (Fig. 4). The
variation of fluorescence intensity at 418 nm with pH (in-
set of Fig. 4) indicates that our compound can be used as
a pH indicator, sensitive to pH ≤ 4. The protonation of
compound 1 at low pH is responsible for this behaviour.
At pH = 2 the emission from two different species is
clearly observed and spectral changes relative to pH = 7
can also be detected in the excitation spectrum (Fig. 5).
The pKa value of a compound can be determined
using Eq. (2),
pH = pKa + log I − IA
IB − I (2)
where I is the fluorescence intensity at a given wave-
length, IA and IB are the fluorescence intensities (at the
same wavelength) when the compound is only in the
acidic form (IA) or only in the basic form (IB). As usu-
ally recommended, it is preferable to determine the ratio
R = I (λ1)/I (λ2) of the fluorescence intensities measured
at two wavelengths (λ1 and λ2), applying Eq. (3) as a
modified Eq. (2) [15],
pH = pKa + log R − RA
RB − R + log
IA (λ2)
IB (λ2)
(3)
where RA and RB are the R values when only the acidic
form or the basic form is present.
In order to determine the pKa value of benzoth-
ienopyridopyrimidone 1, the fluorescence measurements
were extended to lower pH values (Fig. 6).
From Fig. 6, the emission maxima of 418 nm and
465 nm were chosen for λ1 and λ2. The values of IA
and RA were obtained from the spectrum at pH = 0.5,
Fig. 4. Fluorescence spectra of benzothienopyridopyrimidone 1 (10−6 M) at pH 2–10 (λexc =
368 nm). Inset shows the variation of fluorescence intensity with pH (λ = 418 nm).
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Fig. 5. Normalized excitation (λem = 430 nm) and emission (λexc = 368 nm) spectra of
compound 1 at pH = 2 and pH = 7.
while IB and RB were taken at pH = 10 (Figs. 4 and 6).
The fit of Eq. (3) to our experimental data (inset of Fig. 6)
allows the determination of pKa = 2.0 for compound 1.
The usual working range for a pH indicator is about 2 pH
units around the pKa value [15], therefore our compound
can be considered a pH probe for pH ≤ 4.
In lipid vesicles (Fig. 7), the emission spectra of
benzothienopyridopyrimidone 1 are very similar to the
Fig. 6. Fluorescence spectra of benzothienopyridopyrimidone 1 (10−6 M) at pH 0.5–3 (λexc =
368 nm). Inset shows the fit (dotted line) of Eq. (3) to experimental data.
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Fig. 7. Normalized fluorescence spectra of compound 1 (2×10−6 M) in lipid vesicles of
DOPE, DPPC and DODAB (λexc = 368 nm).
emission spectrum in water (Fig. 3) and are also al-
most insensitive to the lipid type molecule of the vesi-
cles. This behaviour indicates that the compound is in
a water-rich environment. To clarify the location of the
compound, the vesicle solutions were passed through fil-
ters of 0.1 µm diameter (Millex). The fluorescence emis-
sion of the filtered solutions was negligible, indicating
that the compound is in the vesicle aqueous interior or
located at the interface, near the polar lipid head groups.
These studies may be important for the incorporation of
our compound in liposomes for controlled drug release
assays.
CONCLUSIONS
Fluorescence studies on a benzothienopyridopyrim-
idone show that it may be useful as a pH indicator for
pH ≤ 4. Its fluorescence in lipid vesicles shows that the
compound prefers a water-rich environment, indicating
that it can be incorporated in the hydrophilic region of li-
posomes for controlled drug release studies. These studies
may be important to develop its use as an antimicrobial
agent or as an anti-tumoral drug.
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